FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced the first patient implant of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System after ...
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) announces the first U.S. implant of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System. The successful ...
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced receipt of CE Mark for the GORE® EXCLUDER® Conformable AAA Device, a product designed for the treatment of ...
Vascular surgeons performed one of the nation's first implants of a Next Generation Conformable GORE TAG Thoracic Endoprosthesis device for the treatment of a traumatic aortic transection as part of a ...
W. L. Gore & Associates, Inc. (Gore) today announced that the Food and Drug Administration (FDA) has consented to the initiation of the clinical study for the new GORE® EXCLUDER® Conformable AAA ...
Delaware-based W L Gore & Associates announced that it will be introducing its Conformable GORE TAG Thoracic Endoprosthesis in the United States after it received approval from the Food and Drug ...
W. L. Gore & Associates, Inc. (Gore) announced that important updates from the Gore Global Registry for Endovascular Aortic Treatment (GREAT) will be presented today at the 2015 Vascular Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results